Covidien' Pharma Unit Mallinckrodt Agrees To Acquire CNS For $100 Mln

Covidien To Present At BOA Merrill Lynch Conference; Webcast At 1:40 PM ET

Covidien Ltd. Host Investor Conference Call At 8:00 AM ET

Covidien Investor Conference Call At 8:00 AM ET

Covidien Revises FY13 Sales Guidance To Reflect Pharmaceuticals Unit Spin-Off

Trade COV now with

9/24/2012 9:48 AM ET

Covidien Public Limited Company. (COV: Quote), Ireland-based healthcare products supplier, on Monday said its pharmaceutical subsidiary, Mallinckrodt, entered into a definitive agreement to acquire all the outstanding capital stock of CNS Therapeutics, Inc, a private pharma company focusing on products involved in the treatment of neurological disorders and intractable chronic pain, for $100 million. The company noted the acquisition shall not be accretive in terms of sales or earnings for the fiscal 2013.

CNS Therapeutics, which holds one marketed product, has a pipeline of pain and spasticity products in development. The deal is believed to close in the fourth quarter of this year, said Covidien in a statement.

The stock is currently trading at $59.17, down $0.60 or 1.00 percent on the NYSE.

Click here to receive FREE breaking news email alerts for Covidien Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

<<Previous 83 Articles

Editors Pick

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.

Stocks Close Modestly Lower But Well Off Worst Levels - U.S. Commentary

After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red.

Obama Outlines Counterterrorism Policy To Confront Shifting Threats

President Barack Obama delivered a highly-anticipated speech on his administration's evolving counterterrorism policies on Thursday, suggesting that the U.S. needs to move away from a "boundless global war on terror." More than a decade after the 9/11 attacks, Obama argued that the terrorist threat has shifted and evolved.